<DOC>
	<DOCNO>NCT01616654</DOCNO>
	<brief_summary>To assess efficacy safety different concentration CD5789 cream subject acne vulgaris purpose dose identification .</brief_summary>
	<brief_title>Dose Range Study CD5789 Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<criteria>Male female subject , 12 35 year old following characteristic : Facial acne severity grade follow : Stratum 1 : IGA score 3 4 Stratum 2 : IGA score 4 Stratum 3 : IGA score 3 4 A minimum 30 noninflammatory lesion fulfills criteria one follow stratum : Stratum 1 : A minimum 20 40 inflammatory lesion , maximum one nodule face . Stratum 2 : More 40 inflammatory lesion , four nodule face . Stratum 3 : Subjects Japanese origin least 20 inflammatory lesion four nodule face . Note : Subjects Japanese origin include Stratum 1 Stratum 2 . Japanese origin define four grandparent born Japan . The presence severe form acne ( acne conglobata , acne fulminans ) secondary acne form ( chloracne , druginduced acne , etc . ) Any uncontrolled serious disease , medical surgical condition , may either interfere interpretation clinical trial result and/or put subject significant risk ( accord Investigator 's judgment ) subject participate clinical trial . Known suspected allergy sensitivities component study drug . Current participation clinical trial drug device OR past participation within 30 day prior Baseline visit .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>